MolPharm Over 1500 Individual Drug Articles!

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on January 25, 2006; DOI: 10.1124/mol.106.022921


0026-895X/06/6904-1079-1082$20.00
Mol Pharmacol 69:1079-1082, 2006

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Related Article
Right arrow All Versions of this Article:
mol.106.022921v1
69/4/1079    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hildebrandt, J. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hildebrandt, J. D.
Perspective

Bring Your Own G ProteinFormula

John D. Hildebrandt

Department of Cell and Molecular Pharmacology, Medical University of South Carolina, Charleston, South Carolina

G protein-coupled receptor (GPCR)-G{alpha} fusion proteins were first characterized more than 10 years ago as a strategy for studying receptor-G protein signaling. A large number of studies have used this approach to characterize receptor coupling to members of the Gs, Gi, and Gq families of G{alpha} subunits, but this strategy has not been widely used to study G{alpha}12 and G{alpha}13. As described in the article by Zhang et al. in this issue of Molecular Pharmacology (p. 1433) characterization of the signaling properties of thromboxane A2 receptor (TP{alpha}) -G{alpha}12 and -G{alpha}13 fusion constructs demonstrates the applicability of this strategy to members of this unique family of G{alpha} subunits, and how this strategy can be used to resolve otherwise difficult problems of receptor pharmacology associated with these proteins. The general strategy of making receptor-G{alpha} fusion constructs has wide applicability to a number of research problems, but there are perhaps also "hidden messages" in how different receptor-G{alpha} subunit fusion pairs behave.


Received January 25, 2006; accepted January 25, 2006

Address correspondence to: John D. Hildebrandt, Department of Cell and Molecular Pharmacology, Medical University of South Carolina, 173 Ashley Ave., 303BSB, Charleston, SC 29425. E-mail: hildebjd{at}musc.edu







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics